SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-16-000124
Filing Date
2016-06-21
Accepted
2016-06-21 16:43:03
Documents
17
Period of Report
2016-06-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kmaymor_06202016.htm 8-K 36946
2 EXHIBIT 99.1 nrxmaymor.htm EX-99.1 4328
3 nrxmaymor001.jpg GRAPHIC 88435
4 nrxmaymor002.jpg GRAPHIC 19891
5 nrxmaymor003.jpg GRAPHIC 8215
6 nrxmaymor004.jpg GRAPHIC 110062
7 nrxmaymor005.jpg GRAPHIC 221326
8 nrxmaymor006.jpg GRAPHIC 138553
9 nrxmaymor007.jpg GRAPHIC 82485
10 nrxmaymor008.jpg GRAPHIC 72670
11 nrxmaymor009.jpg GRAPHIC 79190
12 nrxmaymor010.jpg GRAPHIC 131168
13 nrxmaymor011.jpg GRAPHIC 63973
14 nrxmaymor012.jpg GRAPHIC 75971
15 nrxmaymor013.jpg GRAPHIC 170758
16 nrxmaymor014.jpg GRAPHIC 89200
17 nrxmaymor015.jpg GRAPHIC 137048
  Complete submission text file 0001338095-16-000124.txt   2057052
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 161724811
SIC: 2834 Pharmaceutical Preparations